Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

@article{Huang2020ClinicalFO,
  title={Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China},
  author={Chaolin Huang and Ye-ming Wang and Xing-wang Li and Lili Ren and Jianping Zhao and Y. Hu and Li Zhang and Guohui Fan and Jiuyang Xu and Xiaoying Gu and Zhenshun Cheng and Ting Yu and Jia'an Xia and Yuan Wei and Wen-juan Wu and Xuelei Xie and Wen Yin and Hui Li and Min Liu and Yan Xiao and Hong Gao and Li Guo and Jungang Xie and Guangfa Wang and Rong-meng Jiang and Zhancheng Gao and Qi Jin and Jianwei Wang and Bin Cao},
  journal={Lancet (London, England)},
  year={2020},
  volume={395},
  pages={497 - 506}
}
Summary Background A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients. Methods All patients with suspected 2019-nCoV were admitted to a… Expand

Paper Mentions

Interventional Clinical Trial
This study aims to evaluate the effectiveness of an oral microbiome immunity formula in modulating gut microbiota, enhancing immunity and reducing long-term complications and co… Expand
ConditionsCOVID-19, Probiotic
InterventionDietary Supplement
Interventional Clinical Trial
This is a randomized (4:1) Phase 1 b safety trial in adults who have completed their full COVID-19 vaccination schedule at least 30 days prior to study entry.  
ConditionsCOVID - 19
InterventionDrug
Observational Clinical Trial
The new coronavirus SARS-CoV-2, causes the COVID-19 infection, which showed a form of neurovirulence involving the Central and peripheral Nervous Systems [Baig et al, 2020]. In a… Expand
ConditionsNeurologic Manifestations
InterventionDevice, Diagnostic Test, Genetic
Interventional Clinical Trial
This study is a pilot randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of melatonin in adult outpatients suspected to be afflicted with… Expand
ConditionsCOVID-19
InterventionDrug, Other
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
TLDR
The epidemiological and clinical characteristics of novel coronavirus (2019-nCoV)-infected pneumonia in Wuhan, China, and hospital-associated transmission as the presumed mechanism of infection for affected health professionals and hospitalized patients are described. Expand
Epidemiological and Clinical Characteristics of 17 Hospitalized Patients with 2019 Novel Coronavirus Infections Outside Wuhan, China
TLDR
Data from 17 confirmed cases of novel coronavirus pneumonia infected with 2019-nCoV in Dazhou provided some information that younger age, higher lymphocytes levels and monocytes levels at the diagnoses of 2019- nCoV may contributed to faster recovery and better therapeutic outcome. Expand
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
TLDR
Characteristics of patients who died were in line with the MuLBSTA score, an early warning model for predicting mortality in viral pneumonia, and further investigation is needed to explore the applicability of the Mu LBSTA scores in predicting the risk of mortality in 2019-nCoV infection. Expand
Clinical Characteristics of Patients with Severe Pneumonia Caused by the 2019 Novel Coronavirus in Wuhan, China
TLDR
Clinicians should focus on advanced age, lymphocyte decline, and D-dimer elevation are important characteristics of patients with severe pneumonia to identify high-risk patients at an early stage of the disease. Expand
Clinical Features and Treatment of 221 Patients with COVID-19 in Wuhan, China
TLDR
55 severe patients with elder age and chronic comorbidities, developed more than one complication and the mortality rate was significantly higher in the severe patients compared to that in the non-severe patients, suggesting that the delayed use of corticosteroid might increase the risk of death in ICU. Expand
Clinical features of 2019 novel coronavirus infection in Beijing.
  • Yan Li, Shengyong Xu, +4 authors Huadong Zhu
  • Medicine
  • Journal of thoracic disease
  • 2020
TLDR
No specific symptom was helpful in the diagnosis of 2019-nCoV infection, but relatively low WBC and lymphocyte level might be suggestive to diagnosis. Expand
Hematological characteristics of patients with novel coronavirus pneumonia in intensive care unit
TLDR
2019-nCoV pneumonia should be considered a systemic disease and lymphocyte percentage and blood urea nitrogen, calcium, myohemoglobin, and IL-6 levels can be monitored to prevent progression critical disease. Expand
Clinical Characteristics and Outcomes of 421 Patients With Coronavirus Disease 2019 Treated in a Mobile Cabin Hospital
TLDR
Mobile cabin hospitals provide a safe treatment site for patients with mild COVID-19 symptoms, and provide an effective isolation area to prevent the spread of SARS-CoV-2. Expand
Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province
TLDR
The majority of patients with 2019-nCoV pneumonia present with fever as the first symptom, and most of them still showed typical manifestations of viral pneumonia on chest imaging, suggesting middle-aged and elderly patients with underlying comorbidities are susceptible to respiratory failure and may have a poorer prognosis. Expand
Clinical Features of Patients Infected with the 2019 Novel Coronavirus (COVID-19) in Shanghai, China
TLDR
In this single centre cohort of COVID-19 patients, the most common symptom was fever, and the mostCommon laboratory abnormality was decreased blood T cell counts, which were the risk factors most associated with severity of disease. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 46 REFERENCES
Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study
TLDR
Disease caused by MERS-CoV presents with a wide range of clinical manifestations and is associated with substantial mortality in admitted patients who have medical comorbidities, and major gaps in knowledge of the epidemiology, community prevalence, and clinical spectrum of infection and disease need urgent definition. Expand
Identification of a novel coronavirus in patients with severe acute respiratory syndrome.
TLDR
The novel coronavirus might have a role in causing SARS and was detected in a variety of clinical specimens from patients with SARS but not in controls. Expand
A major outbreak of severe acute respiratory syndrome in Hong Kong.
TLDR
SARS is a serious respiratory illness that led to significant morbidity and mortality in this cohort of 138 cases of suspected SARS during a hospital outbreak in Hong Kong. Expand
A novel coronavirus associated with severe acute respiratory syndrome.
TLDR
A novel coronavirus is associated with this outbreak of severe acute respiratory syndrome, and the evidence indicates that this virus has an etiologic role in SARS. Expand
Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside?
TLDR
It is confirmed that MERS-CoV can drive IL-17 production in humans and highlighted the critical role of IFNα in this initial stage to orchestrate a robust immune response and bring substantial arguments for the indication of early IFN α treatment during MERS -CoV infection. Expand
Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.
TLDR
The clinical picture was remarkably similar to that of the severe acute respiratory syndrome (SARS) outbreak in 2003 and reminds us that animal coronaviruses can cause severe disease in humans. Expand
Coronavirus disease 2019 and cardiovascular system: A narrative review
TLDR
Cardiac involvement as a possible late phenomenon of the viral respiratory infection is an issue that should be anticipated in patients with COVID-19 and combination of proper triage, close monitoring, and avoidance of some drugs that have cardiovascular toxicity are important in the management of cardiovascular system involvement. Expand
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
TLDR
Replication in Sars-CoV-infected macaques of pneumonia similar to that in human beings with SARS, combined with the high prevalence of SARS- CoV infection in SARS patients, fulfill the criteria required to prove that SARS -CoV is the primary cause of Sars. Expand
Review of chest CT manifestations of COVID-19 infection
TLDR
The pertinent clinical findings and the current published data describing chest CT findings in COVID-19 pneumonia, the diagnostic performance of CT for diagnosis, including differential diagnosis, as well the evolving role of imaging in this disease are reviewed. Expand
Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques
TLDR
Treatment of MERS-CoV infected rhesus macaques with IFN-α2b and ribavirin reduces virus replication, moderates the host response and improves clinical outcome. Expand
...
1
2
3
4
5
...